Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results
16 août 2021 18h12 HE
|
Field Trip Health, Ltd.
At June 30, 2021 had approximately $100 million in unrestricted cash and cash equivalents, funds held in trust and short-term investmentsDevelopment of FT-104, a novel psychedelic molecule with...
Field Trip Health Ltd. Schedules First Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, August 17, 2021 at 8:30 am ET
10 août 2021 07h55 HE
|
Field Trip Health, Ltd.
TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP
27 juil. 2021 15h32 HE
|
Field Trip Health, Ltd.
TORONTO, July 27, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic...
Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol "FTRP"
23 juil. 2021 07h50 HE
|
Field Trip Health, Ltd.
TORONTO, July 23, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic...
Field Trip Health Ltd. to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
08 juil. 2021 17h00 HE
|
Field Trip Health, Ltd.
TORONTO, July 08, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results
24 juin 2021 17h05 HE
|
Field Trip Health, Ltd.
Field Trip completes FY2021 as the largest vertically integrated psychedelics company positioned to be a leader in the emerging industryContinues to leverage its early mover opportunity by investing...
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET
17 juin 2021 07h30 HE
|
Field Trip Health, Ltd.
TORONTO, June 17, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound
15 juin 2021 07h30 HE
|
Field Trip Health, Ltd.
TORONTO, June 15, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, today...
Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market
08 juin 2021 07h30 HE
|
Field Trip Health, Ltd.
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...
Field Trip Health Ltd. to Commence Trading on the Toronto Stock Exchange on June 7, 2021
03 juin 2021 07h30 HE
|
Field Trip Health, Ltd.
TORONTO, June 03, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...